이엔에스코리아

비상장계속사업자

ENS KOREA CO.,LTD.

박준한

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

이엔에스코리아

Business Reg. No. 2048188820 · CEO 박준한

I.Investment Overview

Target이엔에스코리아 (2048188820)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명이엔에스코리아
영문명ENS KOREA CO.,LTD.
대표자박준한
사업자등록번호2048188820
법인등록번호1101113124809
설립일2004.12.01
종업원수105명

V.Workforce

105

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW207.32021250.52022320.82023453.72024148.32025
영업이익100M KRW45.8202169.72022110.62023217.820247.62025
순이익100M KRW29.2202147.7202283.92023164.720246.92025
Item20252024202320222021
자산총계460.7억원479억원490억원465.5억원385.4억원
부채총계86.5억원111.7억원272.4억원316.8억원269.4억원
자본총계374.2억원367.3억원217.6억원148.7억원116억원
매출액148.3억원453.7억원320.8억원250.5억원207.3억원
영업이익7.6억원217.8억원110.6억원69.7억원45.8억원
순이익6.9억원164.7억원83.9억원47.7억원29.2억원

VII.Financial Ratios

FY2025 basis

5.15%

영업이익률

4.63%

순이익률

1.49%

ROA

1.83%

ROE

23.12%

부채비율

81.22%

자기자본비율

VIII.R&D Activity

Fields 생명과학 > 산업바이오

Keywords 딸기, 친환경, 마스크팩, 천연, 선인장

YearProjectsPapersPatents
2023000
2022100
2021201
2020200
2019100

IX.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

이엔에스코리아 투심보고서 | Alpha Lenz